A phase II study of muscadine grape skin extract in men with biochemically recurrent prostate cancer

被引：2
|
作者：
Paller, Channing Judith
Heath, Elisabeth I.
Taplin, Mary-Ellen
Stein, Mark N.
Bubley, Glenn J.
Pili, Roberto
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页数：1
相关论文
共 50 条
  • [41] SURVIVAL ESTIMATES OF MEN WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY IN A NATIONAL COHORT
    Stensland, Kristian
    Burns, Jennifer
    Sparks, Jordan
    Vedapudi, Varsha
    Chapman, Christina
    Caram, Megan
    Shin, Chris
    Zaslavsky, Alexander
    Tsodikov, Alexander
    Skolarus, Ted
    JOURNAL OF UROLOGY, 2022, 207 (05): : E245 - E245
  • [42] Precision medicine in the management of men with biochemically recurrent prostate cancer using a novel in vitro approach
    Joshi, A.
    Alinehzad, S.
    Rhee, H.
    Mcpherson, S.
    Gunter, J.
    Williams, E.
    Nelson, C.
    Vela, I.
    BJU INTERNATIONAL, 2019, 123 : 44 - 44
  • [43] Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
    Freedland, Stephen J.
    Luz, Murilo de Almeida
    De Giorgi, Ugo
    Gleave, Martin
    Gotto, Geoffrey T.
    Pieczonka, Christopher M.
    Haas, Gabriel P.
    Kim, Choung-Soo
    Ramirez-Backhaus, Miguel
    Rannikko, Antti
    Tarazi, Jamal
    Sridharan, Swetha
    Sugg, Jennifer
    Tang, Yiyun
    Tutrone, Ronald F.
    Venugopal, Balaji
    Villers, Arnauld
    Woo, Henry H.
    Zohren, Fabian
    Shore, Neal D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (16): : 1453 - 1465
  • [44] A combination herbal supplement for biochemically recurrent prostate cancer
    Dorff, Tanya B.
    Hawes, Debra
    Tsao-Wei, Denice D.
    Quinn, David I.
    Goldkorn, Amir
    Lieskovsky, Gary
    Vogelzang, Nicholas J.
    Groshen, Susan G.
    Pinski, Jacek K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [45] Investigation of potential biomarkers of biochemically recurrent prostate cancer
    Demidenko, R.
    Daniunaite, K.
    Laurinavicius, A.
    Jankevicius, F.
    Jarmalaite, S.
    Lazutka, J. R.
    FEBS JOURNAL, 2014, 281 : 481 - 481
  • [46] A phase II study combining ipilimumab and degarelix with or without radical prostatectomy (RP) in men with newly diagnosed metastatic noncastration prostate cancer (mNCPC) or biochemically recurrent (BR) NCPC.
    Autio, Karen A.
    Eastham, James Andrew
    Danila, Daniel Costin
    Slovin, Susan F.
    Morris, Michael J.
    Abida, Wassim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [47] The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer
    Bilusic, Marijo
    Einstein, David J.
    Karzai, Fatima H.
    Dahut, William L.
    Gulley, James L.
    Aragon-Ching, Jeanny B.
    Madan, Ravi A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 457 - 467
  • [48] ADT intensification to treat biochemically recurrent prostate cancer
    Masone, Maria Chiara
    NATURE REVIEWS UROLOGY, 2024, 21 (03) : 126 - 126
  • [49] Biochemically recurrent prostate cancer: rationalisation of the approach to imaging
    Briody, H.
    Sheehan, M.
    Hanley, M.
    O'Neil, B.
    Dunne, R.
    Lee, M. J.
    Morrin, M. M.
    CLINICAL RADIOLOGY, 2023, 78 (07) : 518 - 524
  • [50] ADT intensification to treat biochemically recurrent prostate cancer
    Maria Chiara Masone
    Nature Reviews Urology, 2024, 21 : 126 - 126
12345